Navigation Links
Cepheid Reports 2013 First Quarter Results
Date:4/18/2013

SUNNYVALE, Calif., April 18, 2013 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today reported revenues for the first quarter of 2013 of $91.9 million, representing growth of 19% from $77.3 million for the first quarter of 2012.  Net income was $0.3 million, or $0.00 per share, which compares to net loss of $5.5 million, or $(0.08) per share, in the first quarter of 2012. 

Excluding employee stock-based compensation and amortization of purchased intangible assets, non-GAAP net income for the first quarter of 2013 was $7.8 million, or $0.11 per share.  This compares to a non-GAAP net loss of $1.2 million, or $(0.02) per share, in the first quarter of 2012.

"This was a solid start to 2013 for Cepheid with strong performance in our commercial clinical reagents driven both by broader test menu utilization by our installed base of more than 3,000 commercial GeneXpert® system customers globally and by new customer adoption," said John Bishop, Cepheid's Chairman and Chief Executive Officer.  "Our leading portfolio of molecular HAI tests continues to drive Cepheid's growth, but we were particularly pleased with the very strong level of interest in Xpert CT/NG in the first quarter, with about 10% of our North American installed base already using or validating the assay." 

Operational Overview

  • By business, total sales were, in millions:
  • Three Months Ended March 31,20132012ChangeClinical Systems

    $
    2.5$
    2.50%Clinical Reagents

    67.154.423%Total Clinical 79.666.919%Non-Clinical & Other

    12.310.418%Total Sales$
    91.9$
    77.319%


  • By geography, total sales were, in millions:
  • Three Months Ended March 31,20132012ChangeNorth AmericaClinical

    $
    52.2$
    45.515%Non-Clinical & Other

    11.48.928%Total North America63.654.417%InternationalClinical

    2
    '/>"/>

    SOURCE Cepheid
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
    2. Cepheid Announces Board of Directors Changes
    3. Cepheid Reports 2012 Second Quarter Results
    4. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
    5. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
    6. Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
    7. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
    8. Cepheid to Webcast Upcoming Financial Presentations
    9. Cepheid Reports Fourth Quarter and Full Year 2011 Results
    10. Cepheid Welcomes Senior Vice President of Human Resources
    11. Global Nano-Materials Market 2002-2016: Nano-Materials Industry, Production Volumes, Revenues and End User Market Demand - MarketResearchReports.Biz
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/21/2014)... Dallas, Texas (PRWEB) November 21, 2014 ... Industry” is a professional and in-depth research report ... information, including its definition, classification, application, and industry ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis. The ...
    (Date:11/21/2014)... - Aequus Pharmaceuticals Inc. (the "Company" or "Aequus") ... a brokered private placement offering (the "Brokered Offering") ... Securities Inc. and Clarus Securities Inc. acted as ... syndicate of agents that also included Wolverton Securities ... Concurrently with the Brokered Offering, the Company also ...
    (Date:11/21/2014)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... 30, 2014.  Biorem,s complete 2014 third quarter financial statements and MD&A ... Summary:Three-months ended September 30, , Nine-months ended ... 2014 , 2013 , 2014 ... , 6,715 , 14,476 Gross profit , ...
    (Date:11/18/2014)... RPS Diagnostics (RPS®) – a ... announces its third annual partnership of the Centers ... About Antibiotics Week from November 17-23. , Get ... designed to highlight the coordinated efforts of CDC, ... for-profit partners to provide education about the importance ...
    Breaking Biology Technology:International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3
    ... 9 VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), ... treatment of peripheral vascular disease,announced today that it plans ... September 30, 2007, before market opens on October 29. ... at 5:30 a.m. PT,/ 8:30 a.m. ET on October ...
    ... /PRNewswire-FirstCall/,-- Evotec AG (Frankfurt Stock Exchange: EVT) is going ... October 2007 at 13.00 pm BST (14.00 pm CET, ... live on the internet. Jorn Aldag, (President & ... Officer) and Dr Tim Tasker, (EVP Clinical,Development) will provide ...
    ... Company to Present Unique Business Model, SAN ... health,and wellness company and recent consecutive year award ... genetic research,announces today that it has been selected ... investor meeting, October 17, 2007 in San,Francisco, CA. ...
    Cached Biology Technology:VNUS Medical Technologies to Report Third-Quarter 2007 Results and Webcast Teleconference on October 29 2Evotec AG: R&D Update on 16 October 2007 Live on the Internet 2Salugen to Present at Nutrition Capital Network's First In-Person Investor Meeting 2
    (Date:11/18/2014)...  The Secure Identity & Biometrics Association (SIBA) ... the formation of The Airport Entry and Exit ... and Biometric Entry and Exit Solutions Framework for ... from BORDERPOL, the international non-profit organization that works ... regarding border security, traveler and migration systems. ...
    (Date:11/15/2014)... , Nov. 13, 2014  While we may still be ... McCoy used in "Star Trek" to gain instant access to ... to work with smartphones and tablets for monitoring and measuring ... healthcare world. This may seem a tad Orwellian to some, ... adopt some of these technological opportunities into their healthcare regime. ...
    (Date:11/7/2014)... Auguste, associate professor, biomedical engineering, in the Grove ... New York, have identified a molecule that could ... most aggressive forms of breast cancer. , Triple ... rate owing to aggressive proliferation and metastasis and ... Auguste,s team, discovered the overexpression of intercellular adhesion ...
    Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
    ... far harder ?cycling the greenhouse gas carbon dioxide more quickly ... ?or outgassed ?as carbon dioxide from Amazonian rivers and wetlands ... other plants and soils of the surrounding landscape, U.S. and ... , It had been hoped that regions such as the ...
    ... cells play a minor role in repairing lung damage, according ... chromosomal differences to analyze the repair process in lung transplant ... lead author Dani Zander, M.D., of The University of Texas ... Florida College of Medicine found that less than 1 percent ...
    ... a minor role in repairing lung damage, according to a ... to analyze the repair process in lung transplant patients. , ... Dani Zander, M.D., of The University of Texas Medical School ... of Medicine found that less than 1 percent of a ...
    Cached Biology News:Amazon source of 5-year-old river breath 2Candida albicans Genome Fully Annotated 2Candida albicans Genome Fully Annotated 3Circulating stem cells play small role in lung repair 2Circulating stem cells play small role in lung repair 3
    ...
    SphingoStripsTM contain fifteen different biologically active, nitrocellulose-immobilized lipids at 100 pmol per spot, which can be assayed for protein binding and specificity using a simple blot ove...
    The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The version upgrade allows upgrade of an established version of...
    ... PrecisION Ion Channel Cell Lines ,High ... ,Ion channels are well known for having ... function and consequently have a key function ... that modulate ion channels have been investigated ...
    Biology Products: